CD4(+) T cells are required for tumor antigen-expressing oHSV glioma therapeutic effect and antigen-specific antibody production.
- DOI
- 10.1016/j.omton.2026.201353
- Published
- 2026 Dec 17
- Container
- Molecular therapy. Oncology
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- supportingDirectory of Open Access Journals: A matching record was returned by DOAJ.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.omton.2026.201353,
title = {CD4(+) T cells are required for tumor antigen-expressing oHSV glioma therapeutic effect and antigen-specific antibody production.},
author = {Hernandez-Aguirre I and Kim D and Hedberg J and Martin AK and Kim Y and Perez P and Behbehani G and Xin G and Cassady KA and Dhital R},
year = {2026},
journal = {Molecular therapy. Oncology},
doi = {10.1016/j.omton.2026.201353},
url = {https://doi.org/10.1016/j.omton.2026.201353}
}RIS
TY - JOUR TI - CD4(+) T cells are required for tumor antigen-expressing oHSV glioma therapeutic effect and antigen-specific antibody production. AU - Hernandez-Aguirre I AU - Kim D AU - Hedberg J AU - Martin AK AU - Kim Y AU - Perez P AU - Behbehani G AU - Xin G AU - Cassady KA AU - Dhital R PY - 2026 JO - Molecular therapy. Oncology DO - 10.1016/j.omton.2026.201353 UR - https://doi.org/10.1016/j.omton.2026.201353 ER -
APA
I, H., D, K., J, H., AK, M., Y, K., P, P., G, B., G, X., KA, C., & R, D. (2026). CD4(+) T cells are required for tumor antigen-expressing oHSV glioma therapeutic effect and antigen-specific antibody production.. Molecular therapy. Oncology. https://doi.org/10.1016/j.omton.2026.201353
Source records
- pubmed · retrieved 2026-11-10T11:12:32.556Z
- europe-pmc · retrieved 2026-11-10T11:12:32.545Z
- doaj · retrieved 2026-11-10T11:12:32.532Z